BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,302.00
- Market cap
- ₹15,755 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.9×Sector 48.7×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Other Announcement
AstraZeneca Pharma India filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold 75% of total equity.
AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.
- Value
- ₹0.02 Cr
Other board meeting date announcements
All →Swiss Military Consumer Goods Board Meeting Date
Swiss Military Consumer Goods Ltd announced its Board meeting is scheduled for 05 Nov 2026 to approve Q1 and H1 FY27 results. No financial figures or decisions are reported yet.
HCL Infosystems Board Meeting Date
HCL Infosystems scheduled a board meeting for November 05, 2026 to approve Q1/H1 results. The trading window closed from October 01, 2026.
Sri Ramakrishna Mills (Coimbatore) Board Meeting Date
Sri Ramakrishna Mills Coimbatore Ltd. will hold its Board meeting on 6 November 2026. The meeting will consider the unaudited standalone financial results for the quarter ended 30 September 2026.
Voltas Board Meeting Date
Voltas has scheduled its Board of Directors meeting for 6 November 2026 to approve Q2 FY27 standalone and consolidated financial results. No financial figures or other decisions are disclosed in this advance notice.
Tilak Ventures Board Meeting Date
Tilak Ventures scheduled a Board meeting for 04 Nov 2026 to consider Q2 and H1 results. No financial figures or decisions are yet announced.
Sonata Software Board Meeting Date
Sonata Software will hold its Board Meeting on 5 November 2026 to consider Q2/H1 results and a possible second interim dividend. The agenda items are proposed and no outcome has been decided yet.